Evolution of the Average Target: Sight Sciences, Inc.

Evolution of the Target Price: Sight Sciences, Inc.

Changes in Analyst Recommendations: Sight Sciences, Inc.

b7688ffbad7576196d90a30e34cfa2.fW3jpbYnErG-0rzM5HB8ET3DZmvduNiCNozj2vOZyb8.DD-q19xVet7YofiNtTYFR071DyiM6enUBunakKPAkcUoWKz1-xcjiIaU3w~5dd37fcd3fbcc8a4d29dcb486cb929d6
08-06 UBS Adjusts Price Target on Sight Sciences to $8 From $7, Maintains Buy Rating MT
07-28 UBS Adjusts Price Target on Sight Sciences to $7 From $11, Maintains Buy Rating MT
01-05 Sight Sciences Shares Rise After Piper Sandler Upgrade MT
01-05 Piper Sandler Upgrades Sight Sciences to Overweight From Neutral, Adjusts Price Target to $9 From $5 MT
25-01-27 UBS Adjusts Price Target on Sight Sciences to $5 From $5.50, Keeps Buy Rating MT
24-12-06 UBS Initiates Sight Sciences at Buy With $5.50 Price Target MT
24-11-04 Lake Street Downgrades Sight Sciences to Hold From Buy, Price Target is $5 MT
24-08-21 Lake Street Initiates Coverage on Sight Sciences With Buy Rating, $10 Price Target MT
24-07-15 Morgan Stanley Raises Price Target on Sight Sciences to $6.50 From $5.40, Keeps Equalweight Rating MT
24-03-08 Stifel Adjusts Price Target on Sight Sciences to $7 From $6, Keeps Buy Rating MT
23-12-04 Morgan Stanley Adjusts Sight Sciences Price Target to $4 From $3, Maintains Equal Weight Rating MT
23-09-18 Stifel Adjusts Price Target on Sight Sciences to $5 From $11, Maintains Buy Rating MT
23-09-15 Citigroup Trims Price Target on Sight Sciences to $4 From $8, Maintains Neutral Rating MT
23-09-13 Morgan Stanley Trims Price Target on Sight Sciences to $4 From $8.40, Maintains Equalweight Rating MT
23-09-12 BofA Securities Downgrades Sight Sciences to Underperform From Neutral, Adjusts Price Target to $4.50 From $10 MT
23-09-12 William Blair Downgrades Sight Sciences to Market Perform From Outperform MT
23-09-12 Piper Sandler Downgrades Sight Sciences to Neutral From Overweight, Adjusts Price Target to $5.50 From $15 MT
23-08-24 Morgan Stanley Downgrades Sight Sciences to Equalweight From Overweight, Adjusts Price Target to $8.40 From $12 MT
23-08-21 Citigroup Trims Sight Sciences Price Target to $8 From $9, Maintains Neutral Rating MT
23-07-11 Citigroup Downgrades Sight Sciences to Neutral From Buy, Adjusts Price Target to $9 From $15 MT
23-07-10 Citigroup Downgrades Sight Sciences to Neutral From Buy, Lowers Price Target to $9 From $15 MT
23-06-26 Stifel Adjusts Price Target on Sight Sciences to $13 From $15, Maintains Buy Rating MT
23-06-06 BofA Securities Adjusts Sight Sciences Price Target to $10 From $13, Maintains Buy Rating MT
23-01-06 Morgan Stanley Adjusts Sight Sciences' Price Target to $15 From $11, Keeps Overweight Rating MT
23-01-06 Stifel Nicolaus Upgrades Sight Sciences to Buy From Hold, Adjusts Price Target to $15 From $10 MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
-3.85%
+21.69%
+21.49%
+33.56%
+59.76%
+22.98%
+28.07%
+9.31%
+34.31%
+9.49%
Average +23.68%
Weighted average by Cap. +27.49%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
9.030USD
Average target price
9.000USD
Spread / Average Target
-0.33%
High Price Target
12.00USD
Spread / Highest target
+32.89%
Low Price Target
8.000USD
Spread / Lowest Target
-11.41%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
  1. Stock Market
  2. Stocks
  3. SGHT Stock
  4. Consensus Sight Sciences, Inc.